Insider Trading Alert - BLUE, BHI And HCP Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Sept. 3, 2014, 85 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $4,255.74 to $5,989,983.27.

Highlighted Stocks Traded by Insiders:

bluebird bio (BLUE) - FREE Research Report

Leschly Nick, who is President and CEO at bluebird bio, sold 10,300 shares at $38.45 on Sept. 3, 2014. Following this transaction, the President and CEO owned 315,001 shares meaning that the stake was reduced by 3.17% with the 10,300-share transaction.

The shares most recently traded at $38.52, up $0.07, or 0.18% since the insider transaction. Historical insider transactions for bluebird bio go as follows:

  • 4-Week # shares bought: 2,941
  • 4-Week # shares sold: 8,000
  • 12-Week # shares bought: 2,941
  • 12-Week # shares sold: 90,283
  • 24-Week # shares bought: 2,941
  • 24-Week # shares sold: 105,283

The average volume for bluebird bio has been 553,900 shares per day over the past 30 days. Bluebird bio has a market cap of $1.1 billion and is part of the health care sector and drugs industry. Shares are up 81.27% year-to-date as of the close of trading on Wednesday.

bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing gene therapies for severe genetic and orphan diseases. The company has a P/E ratio of 6.0. Currently, there are 3 analysts who rate bluebird bio a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BLUE - FREE

TheStreet Quant Ratings rates bluebird bio as a sell. The area that we feel has been the company's primary weakness has been its feeble growth in its earnings per share. Get the full bluebird bio Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Baker Hughes (BHI) - FREE Research Report

Ragauss Peter A, who is Sr. Vice President and CFO at Baker Hughes, sold 12,931 shares at $68.82 on Sept. 3, 2014. Following this transaction, the Sr. Vice President and CFO owned 37,652 shares meaning that the stake was reduced by 25.56% with the 12,931-share transaction.

The shares most recently traded at $69.17, up $0.35, or 0.51% since the insider transaction. Historical insider transactions for Baker Hughes go as follows:

  • 4-Week # shares sold: 3,203
  • 12-Week # shares sold: 46,109
  • 24-Week # shares sold: 149,167

The average volume for Baker Hughes has been 3.2 million shares per day over the past 30 days. Baker Hughes has a market cap of $29.7 billion and is part of the basic materials sector and energy industry. Shares are up 24.88% year-to-date as of the close of trading on Wednesday.

Baker Hughes Incorporated supplies oilfield services, products, technology, and systems to the oil and natural gas industry worldwide. The stock currently has a dividend yield of 1%. The company has a P/E ratio of 23.7. Currently, there are 14 analysts who rate Baker Hughes a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BHI - FREE

TheStreet Quant Ratings rates Baker Hughes as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Baker Hughes Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

HCP (HCP) - FREE Research Report

Klaritch Thomas, who is Executive Vice President at HCP, sold 4,023 shares at $43.31 on Sept. 3, 2014. Following this transaction, the Executive Vice President owned 198,542 shares meaning that the stake was reduced by 1.99% with the 4,023-share transaction.

The shares most recently traded at $43.19, down $0.12, or 0.29% since the insider transaction. Historical insider transactions for HCP go as follows:

  • 4-Week # shares sold: 4,559
  • 12-Week # shares sold: 44,559
  • 24-Week # shares sold: 75,428

The average volume for HCP has been 2.0 million shares per day over the past 30 days. HCP has a market cap of $19.8 billion and is part of the financial sector and real estate industry. Shares are up 19.25% year-to-date as of the close of trading on Wednesday.

HCP, Inc. is an independent hybrid real estate investment trust. The fund invests in real estate markets of the United States. The stock currently has a dividend yield of 5.06%. The company has a P/E ratio of 21.6. Currently, there are 4 analysts who rate HCP a buy, 1 analyst rates it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HCP - FREE

TheStreet Quant Ratings rates HCP as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, growth in earnings per share, expanding profit margins and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full HCP Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Global Stocks Slide as Trump's New Trade War Salvo Ignites Fresh Concern

Global Stocks Slide as Trump's New Trade War Salvo Ignites Fresh Concern

Automakers Slump as Trump Launches National Security Probe into US Car Imports

Automakers Slump as Trump Launches National Security Probe into US Car Imports

Trump Tariff Threat, Deutsche Bank, Elon Musk and Apple - 5 Things You Must Know

Trump Tariff Threat, Deutsche Bank, Elon Musk and Apple - 5 Things You Must Know

Deutsche Bank Confirms Massive Job Cuts as New CEO Christian Sewing Plants Flag

Deutsche Bank Confirms Massive Job Cuts as New CEO Christian Sewing Plants Flag

Ackman Investment Buoys Lowe's; DraftKings Responds to FanDuel Merger -- ICYMI

Ackman Investment Buoys Lowe's; DraftKings Responds to FanDuel Merger -- ICYMI